March 16, 2009--Orexo today announces that the US FDA has approved Edluar (formerly Sublinox) 5 mg and 10 mg sublingual tablets for the short-term treatment of insomnia characterized by difficulties with sleep initiation.
The details can be read here.
No comments:
Post a Comment